Real-time enrollment status for this multiple myeloma clinical trial
Current Status
Recruiting
Checked: October 16, 2026 at 7:50 PM UTC
| NCT Number | NCT02343042 |
| Recruiting Status | Recruiting |
| Condition | Multiple Myeloma |
| Phase | PHASE1 |
| Target Enrollment | 300 participants |
| Active Locations | 16 sites in the US |
| Sponsor | Karyopharm Therapeutics Inc |
| Last Updated on CT.gov | July 15, 2026 (Jul 15, 2026) |
As of October 16, 2026: Clinical trial NCT02343042 is currently recruiting participants. This phase1 study for multiple myeloma is actively seeking new participants at 16 locations across the United States. The study is sponsored by Karyopharm Therapeutics Inc. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT02343042 is actively recruiting participants as of October 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 16 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT02343042 was last updated Jul 15, 2026 (July 15, 2026). HelloStudys verifies this status automatically.